Ligand Pharmaceuticals | Umlaufvermögen



Current Assets Veränderung Datum
Amgen USD 29.03B 2.26B 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
Baxter International USD 8.85B 11M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Glaxosmithkline GBP 17B 301M 2024-12
Insmed USD 1.62B 28.18M 2024-12
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
Ligand Pharmaceuticals USD 331.56M 22.17M 2024-12
MacroGenics USD 217.49M 4.71M 2024-12
Merck USD 38.78B 1.58B 2024-12
Pacira USD 745.13M 55.16M 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Veracyte USD 372.27M 15.41M 2024-12



Ligand Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.